Venmax Drugs and Pharmaceuticals Limited announced earnings results for the second quarter ended September 30, 2019. For the second quarter, the company announced total revenue was INR 1.188 million compared to INR 133,000 a year ago. Net income was INR 246,000 compared to net loss of INR 893,000 a year ago. Basic earnings per share was INR 0.05 compared to basic loss per share of INR 0.17 a year ago. For the half year, total revenue was INR 2.046 million compared to INR 133,000 a year ago. Net loss was INR 154,000 compared to INR 1.077 million a year ago. Basic loss per share was INR 0.03 compared to INR 0.21 a year ago.